{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:46Z","timestamp":1788815266735,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["CNKW2024Y34"],"award-info":[{"award-number":["CNKW2024Y34"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004106","name":"East China Normal University","doi-asserted-by":"publisher","award":["2022JKXYD09004"],"award-info":[{"award-number":["2022JKXYD09004"]}],"id":[{"id":"10.13039\/501100004106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118335","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:01:16Z","timestamp":1786284076000},"page":"118335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Mechanistic insights into cytochrome P450 inhibition by progesterone and its impact on fluoxetine pharmacokinetics"],"prefix":"10.1016","volume":"253","author":[{"given":"Junze","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenmeizi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-8638","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2026.118335_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/13697137.2018.1462792","article-title":"The history of natural progesterone, the never-ending story","volume":"21","author":"Piette","year":"2018","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.bcp.2026.118335_b0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1037\/1064-1297.15.5.427","article-title":"Progesterone: review of safety for clinical studies","volume":"15","author":"Goletiani","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.bcp.2026.118335_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.maturitas.2014.07.009","article-title":"Systemic progesterone therapy\u2013oral, vaginal, injections and even transdermal?","volume":"79","author":"Ruan","year":"2014","journal-title":"Maturitas"},{"issue":"5166","key":"10.1016\/j.bcp.2026.118335_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bmj.1.5166.121","article-title":"Progestogens and their clinical uses: Part II","volume":"1","author":"Swyer","year":"1960","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bcp.2026.118335_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2024.102902","article-title":"Barriers to prescription of hormonal contraception and hormone replacement therapy in gynecological cancer survivors: results of a survey and literature review","volume":"54","author":"Teves","year":"2025","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/endrev\/bnz001","article-title":"Progesterone and breast cancer","volume":"41","author":"Trabert","year":"2020","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2026.118335_b0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ncpcardio1234","article-title":"Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?","volume":"5","author":"Hermsmeyer","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"9340","key":"10.1016\/j.bcp.2026.118335_b0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(99)00008-3","article-title":"The expression and regulation of drug metabolism in human placenta","volume":"38","author":"Pasanen","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2026.118335_b0055","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118335_b0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0193-953X(03)00046-7","article-title":"Assessment and treatment of depression during pregnancy: an update","volume":"26","author":"Nonacs","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"issue":"5","key":"10.1016\/j.bcp.2026.118335_b0065","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/17425255.2020.1750598","article-title":"The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis","volume":"16","author":"Schoretsanitis","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0070","first-page":"58","article-title":"Depression in pregnancy","volume":"48","author":"Mart\u00ednez-Paredes","year":"2019","journal-title":"Rev. Colomb. Psiquiatr. (Engl. Ed.)"},{"key":"10.1016\/j.bcp.2026.118335_b0075","first-page":"1","article-title":"Antidepressant treatment of depression during pregnancy and the postpartum period","volume":"216","author":"McDonagh","year":"2014","journal-title":"Evid. Rep. Technol. Assess (Full Rep)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pharmaceutics13020148","article-title":"Assessing the mechanism of fluoxetine-mediated CYP2D6 inhibition","volume":"13","author":"Deodhar","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bcp.2026.118335_b0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/17425251003677755","article-title":"Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes","volume":"6","author":"Jeong","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118335_b0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cbin.11123","article-title":"Progesterone and fluoxetine treatments of postpartum depressive-like behavior in rat model","volume":"43","author":"Hu","year":"2019","journal-title":"Cell Biol. Int."},{"issue":"7","key":"10.1016\/j.bcp.2026.118335_b0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tips.2022.03.006","article-title":"Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine","volume":"43","author":"Le","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bcp.2026.118335_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2023.106360","article-title":"Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study","volume":"157","author":"Maranho","year":"2023","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2026.118335_b0110","doi-asserted-by":"crossref","first-page":"28482","DOI":"10.1038\/srep28482","article-title":"Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS\/MS and cocktail approach","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118335_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115457","article-title":"Establishment of LC-MS\/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes","volume":"233","author":"Fu","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bcp.2026.118335_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116561","article-title":"Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function","volume":"230","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118335_b0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2017.09.014","article-title":"Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay","volume":"281","author":"Tang","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl","key":"10.1016\/j.bcp.2026.118335_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12479","article-title":"Use of psychotropic drugs during pregnancy and breast-feeding","volume":"445","author":"Larsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.bcp.2026.118335_b0140","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4088\/JCP.v61n1003","article-title":"Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg\/day dose","volume":"61","author":"Beasley","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2026.118335_b0145","first-page":"761","article-title":"Luteal-phase support in assisted reproductive technology: an ongoing challenge","volume":"19","author":"Dashti","year":"2021","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.bcp.2026.118335_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115735","article-title":"P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats","volume":"431","author":"Xu","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cpt.3625","article-title":"ICH M12 drug interaction studies: summary of the efforts to achieve global convergence","volume":"118","author":"Reynolds","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2026.118335_b0160","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1124\/dmd.115.066597","article-title":"The reliability of estimating Ki values for direct, reversible inhibition of cytochrome P450 enzymes from corresponding IC50 values: a retrospective analysis of 343 experiments","volume":"43","author":"Haupt","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bcp.2026.118335_b0165","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/dmd.108.020834","article-title":"Hepatocellular binding of drugs: correction for unbound fraction in hepatocyte incubations using microsomal binding or drug lipophilicity data","volume":"36","author":"Kilford","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2026.118335_b0170","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1095\/biolreprod39.4.764","article-title":"Uptake of progesterone by red blood cells in the rat","volume":"39","author":"Waddell","year":"1988","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/dmd.121.000718","article-title":"Predictive in vitro-in vivo extrapolation for time dependent inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 using pooled human hepatocytes human liver microsomes, and a simple mechanistic static model","volume":"50","author":"Ramsden","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.104046","article-title":"Demonstration of in vitro-in vivo relationship (IVIVR) and virtual bioequivalence (VBE) between progesterone intravaginal rings using physiologically based pharmacokinetic (PBPK) modelling","volume":"115","author":"Thakur","year":"2026","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118335_b0185","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jcem-42-6-1041","article-title":"Levels of free and protein-bound progesterone in plasma during late pregnancy","volume":"42","author":"Batra","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00007495","article-title":"Assessment of the hepatic arterial and portal venous blood flows during pregnancy with doppler ultrasonography","volume":"266","author":"Nakai","year":"2002","journal-title":"Arch. Gynecol. Obstet."},{"issue":"8","key":"10.1016\/j.bcp.2026.118335_b0195","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1471-0528.1990.tb16246.x","article-title":"Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance","volume":"97","author":"Robson","year":"1990","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0149-2918(00)88267-3","article-title":"Oral micronized progesterone","volume":"21","author":"de Ligni\u00e8res","year":"1999","journal-title":"Clin. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2026.118335_b0205","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/humrep\/dey226","article-title":"The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF\/ICSI cycles","volume":"33","author":"Thomsen","year":"2018","journal-title":"Hum. Reprod."},{"issue":"Suppl 161","key":"10.1016\/j.bcp.2026.118335_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12765","article-title":"Pharmaceutical and clinical development of a novel progesterone formulation","volume":"94","author":"Cometti","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/humrep\/dead256","article-title":"Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium","volume":"39","author":"Loreti","year":"2024","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bcp.2026.118335_b0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.14196\/mjiri.31.56","article-title":"Comparison of intramuscular progesterone with oral nifedipine for treating threatened preterm labor: a randomized controlled trial","volume":"31","author":"Haghighi","year":"2017","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bmjsrh-2023-201875","article-title":"Reversal of medication abortion with progesterone: a systematic review","volume":"50","author":"Stifani","year":"2024","journal-title":"BMJ Sex Reprod. Health"},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0230","first-page":"21","article-title":"A case series detailing the successful reversal of the effects of mifepristone using progesterone","volume":"33","author":"Delgado","year":"2018","journal-title":"Issues Law Med."},{"key":"10.1016\/j.bcp.2026.118335_b0235","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.18203\/2394-6040.ijcmph20202970","article-title":"Efficacy of intramuscular progesterone in prevention of preterm birth in patients with history of preterm birth","volume":"7","author":"Shahzad","year":"2020","journal-title":"Int. J. Community Med. Public Health"},{"key":"10.1016\/j.bcp.2026.118335_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1039579","article-title":"Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: a pilot study","volume":"13","author":"Simon","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118335_b0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/JCP.0000000000001821","article-title":"Concentrations of fluoxetine enantiomers decline during pregnancy and increase after birth","volume":"44","author":"Wisner","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118335_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100046","article-title":"Safety in treatment: classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy","volume":"77","author":"Dagher","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118335_b0255","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.apsb.2021.01.007","article-title":"CRISPR-Cas9: a method for establishing rat models of drug metabolism and pharmacokinetics","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118335_b0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.placenta.2022.11.015","article-title":"Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes","volume":"131","author":"Meakin","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.bcp.2026.118335_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117241","article-title":"CYP3A mediates drug-drug interactions between atorvastatin and omeprazole: evidence from in vitro and in vivo studies","volume":"242","author":"Liang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118335_b0270","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1002\/ptr.7664","article-title":"Investigation of cytochrome P450 inhibitory properties of deoxyshikonin, a bioactive compound from Lithospermum erythrorhizon Sieb. et Zucc","volume":"38","author":"Zhang","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.118335_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105281","article-title":"Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method","volume":"79","author":"Gao","year":"2022","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2026.118335_b0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40272-023-00561-2","article-title":"Benefits and risks of antidepressant drugs during pregnancy: a systematic review of meta-analyses","volume":"25","author":"Desaunay","year":"2023","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.bcp.2026.118335_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101932","article-title":"Prevalence and associated factors of antenatal depression: systematic reviews and meta-analyses","volume":"83","author":"Yin","year":"2021","journal-title":"Clin. Psychol. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2026.118335_b0290","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00127-022-02386-9","article-title":"Prevalence and correlates of perinatal depression","volume":"58","author":"Al-Abri","year":"2023","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.bcp.2026.118335_b0295","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jcpt.12267","article-title":"In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates","volume":"40","author":"Ji","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"issue":"6947","key":"10.1016\/j.bcp.2026.118335_b0300","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature01862","article-title":"Crystal structure of human cytochrome P450 2C9 with bound warfarin","volume":"424","author":"Williams","year":"2003","journal-title":"Nature"},{"issue":"34","key":"10.1016\/j.bcp.2026.118335_b0305","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.1074\/jbc.M405427200","article-title":"The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-a resolution","volume":"279","author":"Wester","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118335_b0310","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-7-1","article-title":"A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications","volume":"10","author":"Wagh","year":"2021","journal-title":"Drugs in Context"},{"key":"10.1016\/j.bcp.2026.118335_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116566","article-title":"Construction of cytochrome P450 3A and P-glycoprotein knockout rats with application in rivaroxaban-verapamil interactions","volume":"230","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118335_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117112","article-title":"Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport","volume":"492","author":"Huang","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118335_b0325","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.apsb.2023.12.019","article-title":"Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.bcp.2026.118335_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0335","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40246-023-00461-z","article-title":"Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences","volume":"17","author":"Zhou","year":"2023","journal-title":"Hum. Genomics"},{"issue":"5","key":"10.1016\/j.bcp.2026.118335_b0340","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.4088\/JCP.13r08672","article-title":"Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation","volume":"75","author":"Beach","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2026.118335_b0345","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.jp.7211352","article-title":"Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis","volume":"25","author":"Lattimore","year":"2005","journal-title":"J. Perinatol."},{"issue":"19","key":"10.1016\/j.bcp.2026.118335_b0350","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2026.118335_b0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118335_b0360","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/pharmaceutics16010096","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by metabolism in pregnant subjects and fetuses","volume":"16","author":"Le Merdy","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600674X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600674X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:14:21Z","timestamp":1788812061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600674X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":72,"alternative-id":["S000629522600674X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118335","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into cytochrome P450 inhibition by progesterone and its impact on fluoxetine pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118335"}}